Ivermectin Tablet
Brand names: Stromectol
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Sep 29, 2026 · First posted: Sep 29, 2026 · 1 manufacturers, 1 listed presentations
As of Sep 29, 2026, the FDA lists Ivermectin Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01) NDC 0006-0032-01 |
Merck Sharp & Dohme LLC | Not specified | Product will be discontinued on 10/31/2026 |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Ivermectin Tablet (FDA data as of Sep 29, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Ivermectin Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/ivermectin-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).